PRESENTED By DR. FAISAL ALMOBARAK, MD

Similar documents
Choroidal Detachment after Filtering Surgery. Wan-Chen Ku, MD; Yin-Hsin Lin, MD; Lan-Hsin Chuang, MD; Ko-Jen Yang, MD

THE CURRENT TREATMENT OF GLAUCOMA IS DIrected

TRABECULECTOMY. Dr. Sandra M. Johnson, MD

EXP11677SK. Financial Disclosure. None to be Declared EXP11677SK

WGA. The Global Glaucoma Network

Managing & Avoiding Post-Op Complications in Tube Surgeries

Objectives. Tubes, Ties and Videotape: Financial Disclosure. Five Year TVT Results IOP Similar

Challenging complications of valve implantation. Salah M Al-Mosallamy MD Assistant professor of ophthalmology 2014

Management of Angle Closure Glaucoma Hospital Authority Convention 18 May 2015

TRABECULECTOMY THE BEST AND WORST CANDIDATES

The Anterior Segment & Glaucoma Visual Recognition & Interpretation of Clinical Signs

Choroidal detachment following retinal detachment surgery: An analysis and a new hypothesis to minimize its occurrence in high-risk cases

Trabeculectomy A Review and 2 Year Follow Up

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

Basic microsurgical suturing techniques for beginners

Corporate Medical Policy

AC & ACG Instruction Course Surgical Treatments for PACG

Surgery for COEXISTING CATARACT AND GLAUCOMA:

Coexisting Cataract with Glaucoma & Role of Phacotrabeculectomy. Dr Mudit Agrawal

Five-year Treatment Outcomes in the Ahmed Baerveldt Comparison (ABC)Study

These devices, when FDA approved, are covered for patients with glaucoma that is not adequately controlled with medical therapy.

Subject Index. Canaloplasty aqueous outflow system evaluation 110, 111 complications 118, 119 historical perspective 109, 110

Surgical outcomes of Trab and Tube for Uveitic glaucoma - Experience from a Tertiary Institution

Anterior segment imaging

EFFICACY AND SAFETY OF CANALOPLASTY IN SAUDI PATIENTS WITH UNCONTROLLED OPEN ANGLE GLAUCOMA

XEN GEL STENT MIGS 4/5/2018 OMAHA AND LINCOLN EYE AND LASER INSTITUTES XEN45 GEL STENT WHY ARE WE LOOKING FOR NEW INNOVATIONS IN GLAUCOMA SURGERY?

Sinus trabeculectomy. Preliminary results of IOO operations

Scope Surgical Management of Co-existing Glaucoma and Cataract

Trabeculectomy combined with cataract extraction: a follow-up study

Optometrist's Guide to Glaucoma Surgery. Goals. Glaucoma Philosophy. I have no financial disclosures

Trabeculectomy is the most commonly performed surgery

CLINICAL SCIENCES. Angle-closure Glaucoma Associated With Occult Annular Ciliary Body Detachment

Institution: Glick Eye Institute, Department of Ophthalmology, Indiana University School of Medicine

MORE ON COMBINING OR NOT COMBINING...

Marek Rwkas, 1 Karolina Krix-Jachym, 1 and Tomasz garnowski Introduction

Clinical Study XEN Glaucoma Implant with Mitomycin C 1-Year Follow-Up: Result and Complications

Silicone oil pupillary block after laser retinopexy in aphakic eyes with presumed closed peripheral iridectomy: report of three cases

SILICONE OIL INJECTION INDUCED GLAUCOMA: INCIDENCE AND MANAGEMENT

Surgical Outcomes of Ahmed or Baerveldt Tube Shunt Implantation for medically Uncontrolled Traumatic Glaucoma

Trabeculectomy - A Short Term Follow-up

CATARACT SURGERY IN UVEITIS. Professor Harminder Singh Dua

THE CHRONIC GLAUCOMAS

AHMED AND BAERVELDT GLAUCOMA DRAINAGE IMPLANTS: LONG-TERM RESULTS AND FACTORS INFLUENCING OUTCOME JACOB J., STALMANS I., ZEYEN T.

Update on Clinical Outcomes After Trabectome TM Surgery For Open-angle Glaucoma

2/26/2017. Sameh Galal. M.D, FRCS Glasgow. Lecturer of Ophthalmology Research Institute of Ophthalmology

CLINICAL SCIENCES. Trabeculectomy With Releasable Sutures. development, trabeculectomy

Clinical Study Results of Combined Cyclectomy/Trabeculectomy Procedure Compared with Ahmed Glaucoma Valve Implant in Neovascular Glaucoma Cases

Aqueous Shunts for the Treatment of Glaucoma

CLINICAL SCIENCES. Complications of Baerveldt Glaucoma Drainage Implants. such as the Baerveldt implant are used in the surgical

Phacoemulsification versus Trabeculectomy in Medically Uncontrolled Chronic Angle- Closure Glaucoma without Cataract

Glaucoma is the second leading cause of blindness

MATERIALS AND METHODS

Glaucoma Clinical Update. Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012

5-Fluorouracil as an Adjunct in Glaucoma Filtration Surgery in Younger Age Group

GLAUCOMA SURGERY: FROM THEN TIL NOW (COPE Course ID: GL)

Russ Trenary President & CEO.

Trabeculectomy with ologen implant versus trabeculectomy with mitomycin-c in primary open angle glaucoma: A 2-year study

Surgery of the glaucomas

Pre-operative intraocular pressure does not influence outcome of trabeculectomy surgery: a retrospective cohort study

POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY

Morning Report. copyright The University of Colorado. Ashley Laing 09/01/10 Preceptor- Dr. Pantcheva

CHARTING THE NEW COURSE FOR MIGS

Secondary management and outcome of massive suprachoroidal hemorrhage

STAB INCISION GLAUCOMA SURGERY (SIGS) AMAR AGARWAL

Early results of modified nonpenetrating deep sclerectomy and phacoemulsification in the treatment of open angle glaucoma and cataract

Critical Complication Wonderfully Managed by Vitreoretinal Surgeon

Viscocanalostomy and Canaloplasty. Description. Section: Other Effective Date: July 15, 2015

PRINCIPLES AND TYPES OF GLAUCOMA SURGERIES

Changes of corneal endothelial cell density after EX-PRESS Glaucoma shunt implantation: 2-year follow-up study.

Preliminary ASCRS CyPass Withdrawal Consensus Statement 1

Glaucoma Surgery Louis B. Cantor, MD Jay C. and Lucile L. Kahn Chair and Professor Director of Glaucoma Service

Glaucoma Surgical Treatments. Murray Fingeret, OD Justin Schweitzer, OD Joe Sowka, OD

TO DETERMINE THE LONG-TERM SAFETY AND EFFIcacy

Review of the Ahmed versus Baerveldt study 5-year treatment outcomes

Corporate Medical Policy

Keywords: malignant glaucoma; pars plana vitrectomy; risk factors; complications; intraocular pressure

H E A L A C R O S S L I N K E D H A G L A U C O M A I N J E C TA B L E I M P L A N T Anteis Ophthalmology

WHY MIGS 7/26/18. MIGs in the BIGs A professional level understanding of MIGs. Human Cost of Glaucoma. Standard Treatment Options for Glaucoma

Primary Angle Closure Glaucoma

STAB INCISION GLAUCOMA SURGERY (SIGS)

Measure #192: Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

Aqueous Shunts and Stents for Glaucoma. (90321) (Formerly Aqueous Shunts for Glaucoma)

Observation of curative effects of Ex-PRESS and AGV implantation in the treatment of refractory glaucoma

Progressive Symptomatic Retinal Detachment Complicating Retinoschisis. Initial Reporting Questionnaire

Role of Initial Preoperative Medical Management in Controlling Post-Operative Anterior Uveitis in Patients of Phacomorphic Glaucoma

Comparative Study between Non Penetrating Glaucoma Surgery with and without Implant

Preliminary Scientific Program Update February 24, 2014

P he importance of gonioscopy in diagnosis and management is emphasised.

Trabeculectomy. Draining the aqueous humour reduces the pressure on the optic nerve that causes loss of vision in glaucoma.

New implant for drainage in glaucoma

Ultrasound Biomicroscopy & Glaucoma Care

Viscocanalostomy and Canaloplasty

Secondary Glaucomas. Mr Nick Strouthidis MBBS MD PhD FRCS FRCOphth FRANZCO Consultant Ophthalmologist, Glaucoma Service, Moorfields Eye Hospital

Contents Optic Nerve: The Glaucomatous Optic Nerve Optic Nerve: Clinical Examination Optic Nerve: Heidelberg Retinal Tomography

STAB INCISION GLAUCOMA SURGERY (SIGS)

Trabeculectomy Function after Cataract Extraction

V iscocanalostomy is a non-penetrating filtration procedure

LENS INDUCED GLAUCOMA

Transcription:

PRESENTED By DR. FAISAL ALMOBARAK, MD

Early FAC associated with hypotony is an important complication after glaucoma filtering procedures, especially trabeculectomy. The reported incidence after trabeculectomy varies widely between 2% to 41%. One of the common causes of FAC after trabeculectomy is decreased resistance to aqueous outflow through the sclera with resultant hypotony.

FAC is classified anatomically into 3 grades : Grade 1 : iridocorneal touch limited to the periphery of the iris Grade 2 : contact between the entire iris & the corneal endothelium Grade 3 : total iris apposition + lens ( or vitreous ) & cornea contact In a study of 1240 cases during the first 2 weeks postoperatively, shallow AC ( without iridocorneal touch ) was found in 23.9% of cases, iridocorneal touch in 2.3% & corneolenticular touch in 0.2%. Edmunds et al Eye 2002 Left untreated, FAC may lead to secondary anterior or posterior pole complications. Stewart et al Am J Ophthalmol.1988

COMPLICATIONS ANTERIOR SEGMENT Synechiae POSTERIOR POLE Choroidal effusion Cataract Hypotony maculopathy Corneal decompensation

Grade 3 FAC in phakic eyes is usually an indication for immediate surgical reformation. However, in grade 2 FAC, the exact timing & nature of initial intervention is less clear. An outcome of immediate importance to patients is visual disability after an intervention. The ultimate purpose of filtering procedures is to preserve vision by lowering the IOP.

Purpose & Design Purpose: To evaluate prospectively 3 different approaches to manage FAC because of overfiltration in the early postoperative period after trabeculectomy. Design: Randomized prospective study. All trabeculectomies were performed by a single surgeon using the same technique between 1985 & 1990. Neither releasable sutures nor antimetabolites were employed.

Materials & Methods Inclusion criteria were: Grade 2 FAC within 2 weeks of surgery Same FAC the next day of the initial SLE The cause of FAC is insufficient resistance to aqueous flow through the sclera confirmed by having : low IOP, high bleb, no leakage, open iridectomy & no evidence of suprachoroidal hemorrhage. Exclusion criteria was: Suprachoroidal hemorrhage noticed pre. or intra. operatively

Failure: Persistence, recurrence or progression of grade 2 FAC IOP success: Achievement of predetermined target IOP, or reduction of the IOP greater than 30% relative to preoperative pressure without medications. 36 phakic eyes met the inclusion criteria & were randomly assigned into one of 3 groups

Group 1 Reforming AC using healon until the entire AC is as deep as or deeper than the fellow eye. Group 2 Drainage of choroidal effusion + reforming the AC using BSS. Group 3 No surgical intervention.only pharmacological therapy = Atropine + Phenylephrine + Diamox Wilcoxon rank sum test + Fisher exact test were used

Results VARIABLES GROUP 1 GROUP 2 GROUP 3 # EYES MEAN AGE SEX M F 14 56.8 + 14.4 6 8 10 67.5 + 13.5 6 4 12 65.3 + 21 8 4 DIAGNOSIS POAG TRAUMATIC APHAKIC CACG CHANDLER SYNDROME CONGENITAL INCIDENCE OF FAC MEAN F/U 9 3 0 1 1 0 4.3 + 2.6d 38.4m 5 0 1 3 1 0 5.0 + 2.9d 30.8m 8 0 0 3 0 1 4.6 + 2.5d 38.5m

COMPARISON OF 3 GROUPS HAVING ONLY ONE METHOD OF MANAGEMENT VARIABLE GROUP 1 N=11 GROUP 2 N=10 GROUP 3 N=12 1 Vs 2 (P) 1 Vs 3 (P) 2 Vs 3 (P) MEAN LOSS OF SNELLEN LINES 1.2 + 2.7 3.3 + 3.2 0.5 + 2.2 VISUAL LOSS -2 ( -5.7 ) -2 ( -10.0 ) -1 ( -3.5 ) 0.52 0.17 0.04 IOP FELL > 30% 8 ( 73% ) 6 ( 60% ) 4 ( 33% ) 0.66 0.09 0.39 ACHIEVED IOP TARGET 10 ( 91% ) 7 ( 70% ) 7 ( 58% ) 0.31 0.16 0.67 IOP > 20 mmhg ON MEDICATIONS 1 ( 9% ) 1 ( 10% ) 0 ( 0% ) 1.0 0.48 0.45 REPEAT SURGERY 2 ( 18% ) 3 ( 30% ) 0 ( 0% ) 1.0 0.22 0.08

COMPARISON OF 3 GROUPS WITH SUBSEQUENT INTERVENTIONS VARIABLE GROUP 1 N=11 GROUP 2 N=10 GROUP 3 N=12 1 Vs 2 (P) 1 Vs 3 (P) 2 Vs 3 (P) VISUAL LOSS -1 ( -5.7 ) -1 ( -10.0 ) -1 ( -3.5 ) 0.60 0.26 0.10 IOP FELL > 30% 11 ( 79% ) 9 ( 69% ) 4 ( 33% ) 0.68 0.04 0.11 ACHIEVED IOP TARGET 13 ( 93% ) 10 ( 77% ) 7 ( 58% ) 0.33 0.07 0.41 IOP > 20 mmhg ON MEDICATIONS 1 ( 7% ) 1 ( 8% ) 0 ( 0% ) 1.0 1.0 1.0 REPEAT SURGERY 3 ( 21% ) 3 ( 23% ) 0 ( 0% ) 1.0 0.22 0.22

% OF PATIENTS PATIENT ACHIEVED TARGET IOP 100% 91% 90% 80% 70% 70% 58% 60% 50% 40% 30% 20% 10% GROUP 3 GROUP 2 GROUP 1 0% TREATMENT GROUPS

% OF PATIENTS FALL OF IOP > 30% 73% 80% 70% 60% 60% 50% 33% 40% 30% 20% 10% GROUP 3 GROUP 2 GROUP 1 0% TREATMENT GROUPS

# OF LINES LOST LOSS OF SNELLEN LINES 3.3 3.5 3 2.5 2 1.2 1.5 1 0.5 0.5 GROUP 3 GROUP 2 GROUP 1 0 TREATMENT GROUPS

Discussion Of 33 eyes included in the final analysis, 15 ( 45% ) lost 2 or more lines of VA empasizing the significance of FAC complications. Groups 1 & 2 had greater number of eyes with VA decline of 2 or more lines ( 54% & 60% respectively ) relative to group 3 ( 25% ) ( P = 0.04 between group 2 & 3 ). Eyes treated medically are less likely to lose vision than those managed by surgical intervention as in groups 1 & 2.

Greater rates of IOP success were observed in groups 1 & 2. There was almost a statistically significant difference between groups 1 & 3. ( P = 0.09 ) Though not statistically significant, the trend of 91% ( group 1 ), 70% ( group 2 ) & 58% ( group 3 ) suggests that reformation with viscoelastic is more likely to result in a satisfactory postoperative IOP than medical treatment alone.

Conclusion In conclusion, Reformation of the AC with drainage of choroidal effusion may be associated with great long term trabeculectomy success, but is associated with greater visual acuity loss relative to medical therapy alone. Reformation with viscoelastic resulted in a trend toward lowest final IOP in comparison to medical therapy alone.

Strong points : Prospective randomized study Same surgical methods Weak points : Small sample size Questionable justification to drain choroidal effusion in grade 2 FAC No antimetabolites used